Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids

被引:67
|
作者
Ebeling, PR [1 ]
Erbas, B
Hopper, JL
Wark, JD
Rubinfeld, AR
机构
[1] Royal Melbourne Hosp, Dept Endocrinol & Diabet, Bone & Mineral Serv, Melbourne, Vic 3050, Australia
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Publ Hlth & Community Med, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Dept Thorac Med, Melbourne, Vic 3050, Australia
关键词
D O I
10.1359/jbmr.1998.13.8.1283
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inhaled glucocorticoids are pivotal in maintenance therapy of chronic bronchial asthma; however, conflict exists over their effects on bone and mineral metabolism. We measured bone mineral density (BMD), bone turnover markers, and adrenal steroid hormones in 53 patients (34 female, 19 male) with chronic bronchial asthma who had taken either inhaled beclomethasone or budesonide in doses of greater than or equal to 1500 mu g/day for at least 12 months to determine pathogenetic mechanisms of bone loss. To account for the effect of prior oral glucocorticoid exposure we divided patients into two groups: one with (OG) and the other without (IG) a past history of maintenance (> 1 month) oral glucocorticoid therapy. Lumbar spine (LS) and proximal femur BMDs were similar to 1 SD lower in men and women taking OG or high-dose IG for chronic bronchial asthma, potentially equivalent to a doubling of the risk of fracture at these sites. Prior exposure to OG in women was also associated with lower LS and proximal femur BMDs, while men were more sensitive to the adverse effects of IG on LS and Ward's triangle BMDs, Bone formation markers were decreased; however, bone resorption marker concentrations were normal. All patients had evidence of suppression of both endogenous glucocorticoid and adrenal androgen production. Both total duration of OG and biochemical bone turnover marker concentrations were negatively related to proximal femur and rib BMDs and total body bone mineral content, but not to LS BMD, These were stronger for bone resorption markers. Uncoupling of ongoing normal bone resorption from suppressed bone formation may therefore contribute to glucocorticoid-associated bone loss in asthma, Adrenal androgen suppression may also increase the susceptibility of postmenopausal women in particular to bone loss with OG, Although the effects of high-dose IG on BMD are associated with lower LS BMD in men, this observation should now be investigated further in prospective studies.
引用
收藏
页码:1283 / 1289
页数:7
相关论文
共 50 条
  • [1] Assessment of bone mineral density and markers of bone turnover in children undergoing long-term oral anticoagulant therapy
    Avgeri, Maria
    Platokouki, Helen
    Papadopoulou, Anna
    Douros, Kostas
    Rammos, Spyridon
    Nicolaidou, Polyxeni
    Aronis, Sophia
    [J]. PEDIATRICS, 2008, 121 : S118 - S118
  • [2] Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy
    Avgeri, Maria
    Papadopoulou, Anna
    Platokouki, Helen
    Douros, Kostas
    Rammos, Spyridon
    Nicolaidou, Polyxeni
    Aronis, Sophia
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2008, 30 (08) : 592 - 597
  • [3] Long-term inhaled steroids and bone mineral density in asthma patients
    Sindel, D
    Yaliman, A
    Oral, A
    Klyan, E
    Tarakci, D
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S83 - S83
  • [4] Bone mineral density in women with asthma on long-term inhaled corticosteroid therapy
    Bonala, SB
    Reddy, BM
    Silverman, BA
    Bassett, CW
    Rao, YAK
    Amara, S
    Schneider, AT
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 85 (06) : 495 - 500
  • [5] Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis
    Saag, K.
    Cosman, F.
    De Villiers, T.
    Langdahl, B.
    Scott, B. B.
    Denker, A. E.
    Pong, A.
    Santora, A. C.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (09) : 1879 - 1888
  • [6] Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis
    K. Saag
    F. Cosman
    T. De Villiers
    B. Langdahl
    B.B. Scott
    A.E. Denker
    A. Pong
    A.C. Santora
    [J]. Osteoporosis International, 2021, 32 : 1879 - 1888
  • [7] Effect of long-term oral anticoagulant therapy on bone mineral density and bone turnover markers: a prospective 12 month study
    Stenova, E.
    Steno, B.
    Killinger, Z.
    Baqi, L.
    Payer, J.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2011, 112 (02): : 71 - 76
  • [8] LONG-TERM EFFECTS OF HIGH-DOSE INHALED STEROIDS ON BONE TURNOVER AND DENSITY
    BOULET, LP
    GIGUERE, MC
    MILOT, J
    BROWN, J
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A293 - A293
  • [9] Reduced bone mineral density and high bone turnover in long-term survivors of stem cell transplantation
    Patel, B.
    Terpos, E.
    Todd, J.
    Szydlo, R.
    Apperley, J.
    Goldman, J.
    Salooja, N.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S102 - S103
  • [10] Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover
    Rejnmark, L
    Vestergaard, P
    Heickendorff, L
    Andreasen, F
    Mosekilde, L
    [J]. JOURNAL OF INTERNAL MEDICINE, 2005, 257 (02) : 176 - 184